InsightsA patent portfolio strategy that survives year 12: what to file, what the twenty year bill really is, when to prune, and what to license or sell instead.
InsightsHow to evaluate a deep tech startup: separate science risk from engineering risk, evidence the TRL claim, price the valley, and test the real moat.
InsightsCommercialize university research: license, spin out or assign. The three routes priced against each other, and the deadline that decides which stay open.
InsightsEurope builds 45% of the world's deep tech startups and captures 17% of the funding. The four builder models filling that gap, and how to pick one.
InsightsDeep tech investing for family offices: where patient capital wins, how to diligence science risk, and what a builder with 200+ units deployed sees.
InsightsPatent strategy for deep tech startups: what to protect, when to file against a ten year development clock, where to file, and what a portfolio costs.
InsightsDeep tech and high tech differ by the risk you underwrite first, not by sophistication. The real test, the funding consequences, and the edge cases.
InsightsIs a venture studio worth it for founders? Price the equity against real capital, model dilution after two rounds, and see when the answer flips.
InsightsCarbon removal vs carbon capture: same molecule, different business. Where the CO2 comes from decides credit eligibility, price per tonne and who pays.
InsightsResearch commercialisation is how lab science reaches a market. The plain definition, the four routes out, real timelines, and who keeps what.
InsightsVenture studio vs venture capital: equity ranges, the 10-year fund clock, who carries which risk, and why deep-tech founders usually need both.
InsightsCarbon removal technology ranked by verified tonnes delivered, not tonnes contracted: biochar, BECCS, DAC, enhanced weathering and real costs.
InsightsHow the venture studio business model works: holdco, fund and dual entity structures, where the operating cost sits, and the returns each one has to beat.
InsightsA deep tech venture builder sources lab science, finances it, patents it and staffs it. The five jobs, the equity cost, and how to spot a fake one.
Portfolio · Zero-XEX Venture portfolio company Zero-X ran its EQL-150 prototype gasifier for 120 uninterrupted hours, holding syngas LHV variance below 3% and past the 72-hour mark where decay once appeared. The run validates a new condition-based ash extraction logic and produces the program's anchor reference dataset — proof engineering that makes the machine sellable.
ProductEX FI, the FCA-regulated financial arm of EX Venture, has quietly opened its personal accounts to beta. The first 100 accounts are being onboarded now — multi-currency, instant global payments, no monthly fee. Reach out to get yours opened.
InsightsHow venture studios work in practice: idea sourcing, the kill funnel, the studio bench, cap table at spin-out, and what changes when the science is hard.
InsightsA venture studio builds companies from scratch and takes equity for it. The model, the real equity ranges, the performance data, the deep-tech case.
Portfolio · EX IXEX IX has opened its patent liquidity marketplace to investors, with 24 patent families filed in its first production run and a pipeline of roughly 100 more validated and awaiting filing.